Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

42.02
-0.7200-1.68%
Post-market: 41.00-1.0200-2.43%19:30 EDT
Volume:3.82M
Turnover:161.54M
Market Cap:2.45B
PE:13.59
High:43.27
Open:42.57
Low:41.90
Close:42.74
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:3.40
T/O Rate:7.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.45
PE(LYR):15.51

Loading ...

Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 10, 2025

Correspondence

Form CORRESP - Correspondence
Apr 03, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities